Table 2.
Reference | Rigemen (NO.) | Infection (%) | Damage of liver function (%) | Cardiotoxicity (%) |
---|---|---|---|---|
Yang 2005 [61] |
DA(34) |
44.4 |
13.9 |
8.8 |
HA(22) |
36.4 |
8.8 |
0 |
|
Yuan 2011 [72] | DNR + ATRA(61) |
67.2 |
14.8 |
0 |
HTT + ATRA(54) | 57.4 | 18.5 | 1.9 |
DA daunorubicin + arabinoside, HA homoharringtonine + arabinoside, DNR daunorubicin, HTT homoharringtonine.